Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) FCF Margin (2021 - 2026)

Lucid Diagnostics filings provide 5 years of FCF Margin readings, the most recent being 842.4% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 388.0% to 842.4% in Q4 2025 year-over-year; TTM through Dec 2025 was 987.35%, a 3511.0% increase, with the full-year FY2025 number at 993.23%, up 2922.0% from a year prior.
  • FCF Margin hit 842.4% in Q4 2025 for Lucid Diagnostics, up from 910.67% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 842.4% in Q4 2025 to a low of 12055.26% in Q3 2022.
  • Median FCF Margin over the past 5 years was 1176.43% (2024), compared with a mean of 2355.28%.
  • Biggest five-year swings in FCF Margin: crashed -1095026bps in 2022 and later skyrocketed 1093202bps in 2023.
  • Lucid Diagnostics' FCF Margin stood at 3567.0% in 2021, then fell by -7bps to 3801.79% in 2022, then surged by 74bps to 976.35% in 2023, then increased by 13bps to 846.28% in 2024, then increased by 0bps to 842.4% in 2025.
  • The last three reported values for FCF Margin were 842.4% (Q4 2025), 910.67% (Q3 2025), and 880.0% (Q2 2025) per Business Quant data.